Mark Potter is currently the Director, Regional MSL Lead at Genmab, a position held since 2023. They previously served as an MSL Regional Director and Strategic Partnership Medical Director at AstraZeneca from 2019 to 2021. With a career beginning as a Scientist at Lexicon Pharmaceuticals from 2001 to 2005, Mark also held various roles at Bristol Myers Squibb, including MSL and Regional Field Medical Manager, from 2005 to 2021. Mark earned a Doctor of Philosophy (PhD) in Molecular Genetics from the University of Tennessee-Knoxville between 1988 and 1994.
This person is not in the org chart
This person is not in any teams
This person is not in any offices